Showing all 6 results
Darifenacin Prolonged Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
SILODOSIN 8 MG TABLET
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
Tamsulosin 0.4 Mg + Dutasteride 0.5 Mg Tablets
FreeA tablet or capsule containing Tamsulosin 0.4 mg + Dutasteride 0.5 mg is a dual-action combination medication used to treat moderate to severe symptoms of Benign Prostatic Hyperplasia (BPH), or an enlarged prostate.
Tamsulosin 0.4 mg tablet
FreeA Tamsulosin 0.4 mg tablet (or capsule) is a selective alpha-1 adrenergic receptor antagonist used to treat symptoms of an enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH).
Tamsulosin 0.4Mg + Finasteride 5Mg Tablet
FreeA Tamsulosin 0.4mg + Finasteride 5mg tablet is a combination medication used to manage Benign Prostatic Hyperplasia (BPH), also known as an enlarged prostate. This dual therapy is designed to provide both rapid symptom relief and long-term reduction of prostate size.
